Matrix metalloproteinase-2 as a target for head and neck cancer therapy

Author： Chien Ming-Hsien   Lin Chiao-Wen   Cheng Chao-Wen   Wen Yu-Ching   Yang Shun-Fa  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.2, 2013-02, pp. : 203-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Electroporation Therapy of Skin Cancer in the Head and Neck Area

By LANDSTRÖM FREDRIK J.   NILSSON CHRISTER O.S.   CRAFOORD SVEN   REIZENSTEIN JOHAN A.   ADAMSSON GUN-BRITT M.   LÖFGREN LENNART A.  

Dermatologic Surgery, Vol. 36, Iss. 8, 2010-08 ,pp. : 1245-1250

Elsevier

Access to resources Recommend Favorite

Clinical Applications of Gene Therapy in Head and Neck Cancer

By  

Current Gene Therapy, Vol. 7, Iss. 6, 2007-12 ,pp. : 446-457

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Strategies in Therapy of Head and Neck Cancer

By  

Current Cancer Drug Targets, Vol. 11, Iss. 4, 2011-05 ,pp. : 465-478

Bentham Science Publishers

Access to resources Recommend Favorite

Nuclear Factor Kappa B: A Potential Target to Persecute Head and Neck Cancer

By  

Current Drug Targets, Vol. 18, Iss. 2, 2016-12 ,pp. : 232-253

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects

By Fingleton Barbara  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 3, 2003-06 ,pp. : 385-397

Informa Healthcare

Access to resources Recommend Favorite